A critical-severity vulnerability in the vm2 Node.js sandbox library, tracked as CVE-2026-22709, allows escaping the sandbox and executing arbitrary code on the underlying host system.

From fine-tuning open source models to building agentic frameworks on top of them, the open source world is ripe with ...

After three years of development, the team behind Skip, a solution designed to create iOS and Android apps from a single ...

Vulnerabilities in the NPM, PNPM, VLT, and Bun package managers could lead to protection bypasses and arbitrary code ...

The Independent Bookshop Top 20 has seen a new number one this week as the British Library’s latest instalment in their Tales of the Weird series has flown to the top spot, according to the latest ...

Year-end turbulence only modestly slowed the surge in silver, gold and copper in 2025, with the metals providing important ballast to portfolios as President Donald Trump’s tariffs rattled markets and ...

ST. LOUIS – A suspect was injured after attempting to break into a St. Louis Public Library branch early Monday morning in south St. Louis. The incident occurred around 6 a.m. Monday morning at the ...

For investors worldwide, 2025 was anything but boring. President Donald Trump’s return to the Oval Office shook up global markets. His aggressive tariff agenda quickly became one of the most ...

GameSpot may get a commission from retail offers. Splitgate developer 1047 Games has reacted to the online commentary regarding the recent re-launch of the shooter Splitgate: Arena Reloaded. The game ...

The S & P 500 concludes 2025 after reaching a fresh all-time high just a few days ago. What's more telling, however, is how the index worked its way back to that Oct. 27 peak. Over the past two months ...

From artificial intelligence-driven efficiency to transmission bottlenecks, power industry insiders share their perspectives on the opportunities and obstacles shaping 2026 and beyond. The power ...

Pfizer is penning a cancer discovery pact with Cartography Biosciences that could max out at $865 million biobucks. The Big Pharma is offering the California biotech up to $65 million in upfront, near ...